Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Fatty Liver Disease”

580 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 580 results

Post-approval studies (Phase 4)Study completedNCT03910361
What this trial is testing

Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases

Who this might be right for
Type2 DiabetesNon-Alcoholic Fatty Liver Disease
Dong-A ST Co., Ltd. 51
Large-scale testing (Phase 3)Active Not RecruitingNCT03900429
What this trial is testing

Evaluate the Efficacy and Safety of MGL-3196 (Resmetirom) in Patients With NASH and Fibrosis

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Madrigal Pharmaceuticals, Inc. 1,759
Not applicableActive Not RecruitingNCT06240039
What this trial is testing

Direct Versus Indirect Effect of Amino Acids on Hepatokines

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseObesity
University of Copenhagen 30
Not applicableLooking for participantsNCT07400367
What this trial is testing

Impact of a Probiotic Supplementation With Lifestyle Modification on Liver Steatosis, Fibrosis, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Liver ElastographyLiver SteatosisLiver Function Test+2 more
Fu Jen Catholic University Hospital 80
Large-scale testing (Phase 3)Active Not RecruitingNCT04951219
What this trial is testing

Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)

Who this might be right for
Non-Alcoholic Fatty Liver Disease
Madrigal Pharmaceuticals, Inc. 810
Not applicableUnknownNCT05790057
What this trial is testing

Subclinical Cardiovascular Changes in NAFLD Patient (Predictive Value of Speckle Tracking Echocardiography )

Who this might be right for
Liver Steatoses
Assiut University 60
Not applicableNot Yet RecruitingNCT07797101
What this trial is testing

Body-weight Reduction Effect on Portal Hypertension in Compensated Cirrhosis

Who this might be right for
CirrhosisPortal HypertensionFatty Liver Disease+1 more
The Second Affiliated Hospital of Chongqing Medical University 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07310407
What this trial is testing

Rutin and Vitamin C in Patients With Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Who this might be right for
NAFLD
Ain Shams University 120
Not applicableNot Yet RecruitingNCT06668753
What this trial is testing

Effect of SGLT2 Inhibitors on NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy

Who this might be right for
Effect of SGLT2 Inhibitors NAFLD in Type 2 Diabetic Patients with Diabetic Nephropathy
Assiut University 114
Not applicableStudy completedNCT02784925
What this trial is testing

Evaluate Patients With Chronic Hepatitis by Three-dimensional Force-controlled Ultrasound Measurement

Who this might be right for
Fatty Liver
Taipei Medical University WanFang Hospital 30
Not applicableUnknownNCT04985188
What this trial is testing

Quantitative Ultrasound for Diagnosing Hepatic Steatosis in Nonalcoholic Fatty Liver Multicenter Study

Who this might be right for
Diagnoses Disease
Seoul National University Hospital 112
Post-approval studies (Phase 4)Study completedNCT01006889
What this trial is testing

Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease

Who this might be right for
Nonalcoholic Fatty Liver DiseaseType 2 Diabetes Mellitus
University of Florida 24
Very early researchNot Yet RecruitingNCT07198516
What this trial is testing

The Improvement Effect of Henggliejin on Fatty Liver in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver:

Who this might be right for
NAFLDDiabete Type 2
Fujian Medical University Union Hospital 149
Not applicableNot Yet RecruitingNCT06773221
What this trial is testing

The Efficacy and Safety of Chiglitazar in Patients with MAFLD-related Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Fatty Liver DiseaseCompensated Liver Cirrhosis
Beijing Friendship Hospital 195
Not applicableStudy completedNCT06697977
What this trial is testing

Effects of Phytosterol Supplementation on Liver Function and Inflammatory Status in Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLDInsulin ResistanceMetabolic Syndrome+4 more
University of Jordan 27
Post-approval studies (Phase 4)Study completedNCT02331589
What this trial is testing

Anti-fatigue Effect of Korean Red Ginseng in Patients With Non-alcoholic Hepatitis

Who this might be right for
Fatigue
Chuncheon Sacred Heart Hospital 75
Large-scale testing (Phase 3)WithdrawnNCT01384578
What this trial is testing

Pentoxiphylline and Vitamin E Versus Vitamin E in Patients With Non- Alcoholic Steatohepatitis

Who this might be right for
Non Alcoholic Steatohepatitis
Institute of Liver and Biliary Sciences, India
Testing effectiveness (Phase 2)Study completedNCT03656068
What this trial is testing

An Evaluation of the Safety and Efficacy of Nitazoxanide on Collagen Turnover in NASH Patients With Fibrosis

Who this might be right for
Non-alcoholic SteatohepatitisFatty LiverFibrosis, Liver+1 more
Pinnacle Clinical Research, PLLC 21
Not applicableNot Yet RecruitingNCT07713992
What this trial is testing

Efficacy and Safety of Mazdutide in Patients With Type 2 Diabetes Mellitus and Moderate to Severe Nonalcoholic Fatty Liver Disease Previously Treated With Semaglutide

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Nonalcoholic Fatty Liver Disease (NAFLD) With History of Diabetes Melitus
Tianjin Medical University 72
Not applicableStudy completedNCT02649049
What this trial is testing

Dietary Determinants in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)

Who this might be right for
Dietary IntakeNAFLD
National Nutrition and Food Technology Institute 1,200
Next Page